发明名称 Vaccination by circumventing preexistent immunity
摘要 Methods and compositions are disclosed for improving vaccination in a subject with preexistent antibodies to the antigenic component of the immunizing vaccine. By temporarily sequestering, disabling, and/or suppressing preexistent antibodies and/or Fc-mediated mechanisms according to the various example embodiments, the target antigenic component of a vaccine has an increased opportunity to enter antigen-presenting cells through the same pathway that it would use in seronegative subjects. A balanced immune environment is thereby restored and B cells are properly activated to produce antigen-specific antibodies following vaccination.
申请公布号 US9149508(B1) 申请公布日期 2015.10.06
申请号 US201213660035 申请日期 2012.10.25
申请人 Sigmovir Biosystems, Inc. 发明人 Boukhvalova Marina S.;Blanco Jorge C. G.
分类号 C07K14/765;A61K38/21;A61K39/00 主分类号 C07K14/765
代理机构 代理人 Cox George W.
主权项 1. A method of vaccination against respiratory syncytial virus (RSV) in an animal or human, comprising: (a) administering a vaccine, and (b) administering at least one agent that binds to preexistent antibodies directed to the antigenic component of said vaccine, wherein said at least one agent is selected from the group consisting of recombinant Protein A, native Protein A, recombinant Protein G, native Protein G, recombinant Protein A/G, native Protein A/G, and ultraviolet light-inactivated RSV,whereby the immunosuppressive effect of said preexistent antibodies on said vaccination is circumvented.
地址 Rockville MD US